# Relypsa Inc: Form D filings

Relypsa Inc, a pharmaceuticals company in Santa Clara, CA, filed 7 Form D notices with the SEC between 2010 and 2012. The latest, on December 11, 2012, reports $65 million sold of a $80 million offering to 15 investors.

Find out what Relypsa Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Relypsa%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Relypsa%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Frelypsa-inc-1416792)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Relypsa%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Relypsa%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Frelypsa-inc-1416792)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 5301 PATRICK HENRY DRIVE, Santa Clara, CA, 95054
- Phone: (408) 200-9500
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1416792

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 11, 2012 | Amendment | $80,000,200 | $65,000,192 | $15,000,008 | 15 | Jul 26, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416792/000114036112050442/0001140361-12-050442-index.htm) |
| Oct 5, 2012 | Amendment | $80,000,200 | $62,412,304 | $17,587,896 | 14 | Jul 26, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416792/000114036112043086/0001140361-12-043086-index.htm) |
| Aug 10, 2012 | New notice | $80,000,200 | $49,677,652 | $30,322,548 | 13 | Jul 26, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416792/000114036112036269/0001140361-12-036269-index.htm) |
| Aug 8, 2011 | Amendment | $70,129,747 | $70,129,747 | $0 | 12 | Sep 3, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416792/000141679211000001/0001416792-11-000001-index.htm) |
| Sep 14, 2010 | New notice | $70,129,747 | $35,129,747 | $35,000,000 | 12 | Sep 3, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416792/000141679210000004/0001416792-10-000004-index.htm) |
| Jul 30, 2010 | Amendment | $6,000,060 | $6,000,060 | $0 | 11 | Apr 27, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416792/000141679210000003/0001416792-10-000003-index.htm) |
| May 3, 2010 | New notice | $4,000,040 | $4,000,040 | $0 | 11 | Apr 27, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416792/000141679210000002/0001416792-10-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jonathan M. Silverstein | Director |  |
| Gerrit Klaerner | Executive Officer, Director |  |
| Thomas M. Schuetz | Director |  |
| Scott M. Rocklage | Director |  |
| Ron M. Hunt | Director |  |
| Paul M. Hastings | Director |  |
| Wilhelm M. Stahl | Executive Officer |  |
| Jerry M. Buysse | Executive Officer |  |
| Klaus M. Veitinger | Director |  |
| Ronald Krasnow | Executive Officer |  |
| Lance M. Berman | Executive Officer |  |
| Claire M. Lockey | Executive Officer |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Dec 10, 2012](https://specstream.ai/data/form-d/week/2012-12-10) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Relypsa Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).